• Fri, January 31, 2025

by: BBC

Chelsea spending 'skews market' in WSL - Skinner

Manchester United boss Marc Skinner is pleased to see extra investment in the women's game, but believes Chelsea's spending in the January transfer window "skews the market".

by: FXStreet

Altcoins LINK, AVAX and LTC Price Prediction: Double-digit gains ahead

However, the RSI reads 44 and points upwards. For the bullish momentum to sustain, the RSI must close above the neutral level of 50 and rise. Like Chainklink, AVAX's MACD indicator on the daily chart is about to flip a bullish crossover. If it succeeds on a daily basis, it would give a buy signal and suggest an uptrend.

by: MoneyWeek

Is now a good time to invest in infrastructure?

While high interest rates have been a headwind for infrastructure stocks and trusts in recent years, the picture could be improving, as the UK government unveils plans to boost infrastructure investment.

by: Kiplinger

Intel Earnings Do Little to Excite Investors: What to Know

Intel stock is struggling for direction Friday after the chipmaker reported a fourth-quarter beat but gave weak guidance. Here's what Wall Street has to say.

by: FXStreet

IBM stock rockets to new all-time high on AI bookings

Evercore raised its price tag on IBM stock from $240 to $275, retaining its Outperform rating. Software, however, appears to be the only growth business. It reported $7.9 billion in revenue in Q4, up 10% YoY.

by: MSN

Is It Worth Investing in Dell Technologies (DELL) Based on Wall Street's Bullish Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

by: MSN

AbbVie stock rises on solid annual profit guidance, Q4 beat

AbbVie (NYSE:ABBV) saw its shares jump more than 4% in premarket trading Friday after the company's profit guidance for the fiscal 2025 year exceeded analyst expectations, driven by strong sales in immunology drugs Skyrizi and Rinvoq.

by: MSN

ASML Holding N.V. (ASML) Stock Falls 17% Amid Government Scrutiny and Export Curbs, Despite Monopoly in Lithography Equipment

We recently compiled a list of the Morgan Stanley's 15 Best European AI Stocks. In this article, we are going to take a look at where ASML Holding N.V. (NASDAQ:ASML) stands against Morgan Stanley's other European AI stocks.

by: MSN

Billionaire Philippe Laffont sold Nvidia, AMD and invested heavily in two companies dominating a market that may reach beyond $100 billion; which are the stocks?

Analysts predict the weight loss drug market to grow between $100 billion and $130 billion by 2030, as per a report.

by: WOPRAI

Short squeeze is starting in shares of OCUL at $7.97, after crossing above the $7.831 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BCRX at $7.945, after crossing above the $7.908 Trigger Price

by: MSN

3 Blue-Chip Dividend Stocks Every Canadian Should Own

Sometimes investors think too hard when they could simply pick up these blue-chip stocks. The post 3 Blue-Chip Dividend Stocks Every Canadian Should Own appeared first on The Motley Fool Canada.

by: MSN

Atlassian stock soars 18% on earnings beat, strong outlook

Atlassian Corp Plc (NASDAQ:TEAM) shares surged 18% in after-hours trading on Thursday after the team collaboration software provider reported better-than-expected second-quarter results and issued an upbeat revenue forecast.

by: WOPRAI

Short squeeze is starting in shares of CHGCF at $46.01, after crossing above the $44.115 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of GSAT at $1.585, after crossing above the $1.576 Trigger Price

by: MSN

Sebi bans finfluencers from using live stock prices, tightens crackdown on illegal advisories

MUMBAI: The markets regulator Sebi, which has been after the so-called financial influencers or finfluencers who are tricking the gullible public into investing in stocks they get paid to recommend, for long,

by: MSN

OTE sets financial events for 2025, includes dividend date

ATHENS - Hellenic Telecommunications Organization S.A. (ASE: HTO), known as OTE Group, has laid out its financial calendar for the year 2025, including key dates for financial results announcements and dividend payments.

by: WOPRAI

Short squeeze is starting in shares of GRLRF at $0.71, after crossing above the $0.648 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TMQ at $1.28, after crossing above the $1.272 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of STKL at $7.54, after crossing above the $7.502 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of VYNE at $2.439, after crossing above the $2.41 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of VIV at $8.87, after crossing above the $8.789 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of VIAV at $12.49, after crossing above the $12.273 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TREX at $74.325, after crossing above the $74.291 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SPND at $2.49, after crossing above the $2.464 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SIGI at $83.44, after crossing above the $83.112 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SETO at $0.037, after crossing above the $0.028 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PMNT at $1.1, after crossing above the $1.078 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MKSI at $116.09, after crossing above the $113.422 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MAPSW at $0.09, after crossing above the $0.073 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of HUIZ at $3.5, after crossing above the $3.483 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of DPG at $11.834, after crossing above the $11.831 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CZNC at $21.57, after crossing above the $21.452 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CMTV at $17.99, after crossing above the $17.641 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ASCUF at $1.154, after crossing above the $1.145 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of AP at $2.61, after crossing above the $2.581 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of UCTT at $36.631, after crossing above the $36.493 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TDW at $55.55, after crossing above the $55.489 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of LVO at $1.365, after crossing above the $1.221 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of IFNNY at $32.97, after crossing above the $32.867 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CZFS at $64.9, after crossing above the $63.969 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CFLT at $31.065, after crossing above the $30.664 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SLAMU at $11, after crossing above the $10.123 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PPCB at $9, after crossing above the $0.003 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of OCEL at $2.65, after crossing above the $0.023 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of HONE at $11.72, after crossing above the $11.717 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CUBE at $42.065, after crossing above the $42.006 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ANGO at $12.655, after crossing above the $12.609 Trigger Price

IBM stock rockets to new all-time high on AI bookings

Evercore raised its price tag on IBM stock from $240 to $275, retaining its Outperform rating. Software, however, appears to be the only growth business. It reported $7.9 billion in revenue in Q4, up 10% YoY.
IBM's stock surged to a new all-time high following the announcement of significant AI-related bookings in the last quarter of 2024. The company reported a 6% year-over-year revenue increase, reaching $17.38 billion, with AI being a key driver. IBM's CEO, Arvind Krishna, highlighted the company's strategic focus on AI, particularly through its watsonx platform, which has seen substantial adoption across various industries. This growth in AI bookings not only reflects IBM's successful pivot towards AI and cloud computing but also underscores the increasing market demand for AI solutions. The positive market reaction was further fueled by IBM's optimistic outlook for 2025, projecting continued growth in AI and hybrid cloud sectors.

Read the Full FXStreet Article at:
https://www.fxstreet.com/news/ibm-stock-rockets-to-new-all-time-high-on-ai-bookings-202501301725

Like: 👍